Efficacy of Wnt-1 monoclonal antibody in sarcoma cells

BACKGROUND: Sarcomas are one of the most refractory diseases among malignant tumors. More effective therapies based on an increased understanding of the molecular biology of sarcomas are needed as current forms of therapy remain inadequate. Recently, it has been reported that Wnt-1/β-catenin signali...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikami, Iwao, You, Liang, He, Biao, Xu, Zhidong, Batra, Sonny, Lee, Amie Y, Mazieres, Julien, Reguart, Noemi, Uematsu, Kazutsugu, Koizumi, Kiyoshi, Jablons, David M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1164405/
https://www.ncbi.nlm.nih.gov/pubmed/15913453
http://dx.doi.org/10.1186/1471-2407-5-53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1164405/
https://www.ncbi.nlm.nih.gov/pubmed/15913453
http://dx.doi.org/10.1186/1471-2407-5-53

Ejemplares similares